Acute Bronchiolitis Diagnosis Treatment and Prevention

This report was prepared and written byEbru Yalcin, Bulent Karadag, Nevin Uzuner, HasanYuksel, Fuat Gurkan, Derya Ufuk Altıntas, Elif Dagli,Remziye Tanac, Haluk CokugrasThe full text of the report is published in Turkish inTurkish Thoracic Journal 2009;10 (Supplement 1): 7-9Türk Toraks DerneğiTurkish Thoracic SocietyTurkish Thoracic SocietyTuran Güneş Boulevard, No: 175/19 Oran-Ankara-TurkeyTelephone Number: +90 312 490 40 50Fax Number: +90 312 490 41 42E-mail address: toraks@toraks.org.trWebsite: www.toraks.org.tr

PREVENTION• Avoid smoking at indoor environment.• Training about the importance of hand washing and use of themask• Palivizumab (RSV monoclonal antibody) is recommended forhigh-risk infants.• Palivizumab (RSV monoclonal antibody) should be consideredfor children at highest risk of severe RSV infection including:- Children < 2 yr of age with chronic lung disease requiringsupplemental oxygen or other medical therapy currentlyor within the 6 mo before the RSV season should receiveprophylaxis for the 2 RSV seasons if they have severe lungdisease, and only for the 1st RSV season with less severelung disease. Children < 2 yr of age with hemodynamicallysignificant congenital heart disease are also candidates forthis therapy.- Infants without bronchopulmonary dysplasia;- Infants born at

Türk Toraks DerneğiTurkish Thoracic Society